Prof. Banafshé Larijani Chair

Banafshé Larijani is currently the Director of the Consortium for Precision Health (CPH) at
the University of Bath. CPH is an evolution from the Centre of Therapeutic innovation which
she directed from 2019 to 2025. CPH is an Internationally faced translational research
consortium with the mission to implement precision cross-disciplinary science to lead to
personalised treatment of patients across many pathologies.

Her laboratory, Cell Biophysics, is a cutting-edge cross-disciplinary platform, that has drawn
upon the physical sciences to develop novel avenues for investigation of biological
processes in signalling pathways. The outcomes of her fundamental research, involving the
application of quantitative imaging (FRET-FLIM) for investigating molecular mechanisms and
dynamics of phosphoinositide-modifying and phosphoinositide-dependent enzymes have
resulted in their application to various clinical objectives.

While in Northern Spain (2014-2018), the cancer diagnostic/prognostic company, she co-
founded and directed, FASTBASE SOLUTIONS S.L., won European and French Awards for
best “predictive cancer diagnostic test”.

Her team has employed quantitative molecular biology to investigate in situ molecular
mechanisms in the various signalling pathways. These studies led to applying molecular
imaging methods in clinical settings. Their endeavour being to address pertinent questions
regarding the exploitation of functional proteomics, as opposed to expressional proteomics in
diagnostics and prognostics of various types of pathologies

Read More